Literature DB >> 1094946

Relationship between polyene resistance and sterol compositions in Cryptococcus neoformans.

S J Kim, J Kwon-Chung, G W Milne, W B Hill, G Patterson.   

Abstract

Six mutants of Cryptococcus neoformans resistant to nystatin and pimaricin and three mutants resistant to amphotericin B were isolated by ultraviolet irradiation techniques from two wild-type strains. The major sterols of the wild-type strains were Delta(7)-ergosten-3beta-ol and ergosterol. All six mutants resistant to nystatin and pimaricin showed either loss of ergosterol and concurrent production of Delta(7, 22)-ergostadien-3beta-ol and Delta(7)-ergosten-3beta-ol, or loss of both the wild-type sterols, with production of Delta(8(9))-ergosten-3beta-ol and Delta(5, 8(9), 22)-ergostatrien-3beta-ol. The mutants producing Delta(7, 22)-ergostadien-3beta-ol and Delta(7)-ergosten-3beta-ol showed relatively low levels of resistance to nystatin and pimaricin, whereas the mutants producing Delta(8(9))-ergosten-3beta-ol and Delta(5, 8(0), 22)-ergostatrien-3beta-ol showed a high level of resistance to either drug. Although highly resistant to amphotericin B, however, the three mutants produced sterol compositions identical to those of the wild types, indicating that the strains acquired resistance other than by alteration of the membrane sterols. The mutants producing Delta(8(9)) and Delta(5, 8(9), 22) sterols were not virulent for mice, showed reduced growth rates at 25 C, and failed to grow at 37 C. The other mutants showed a slightly reduced rate of growth both at 25 and 37 C, and the virulence in mice was slightly reduced in comparison with that of the wild types. These comparisons were on gross observations and were not statistically analyzed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1094946      PMCID: PMC429080          DOI: 10.1128/AAC.7.1.99

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Sterol biosynthesis in antibiotic-resistant yeast: nystatin.

Authors:  M Fryberg; A C Oehlschlager; A M Unrau
Journal:  Arch Biochem Biophys       Date:  1974-01       Impact factor: 4.013

2.  Polyene resistance and the isolation of sterol mutants in Saccharomyces cerevisiae.

Authors:  S W Molzahn; R A Woods
Journal:  J Gen Microbiol       Date:  1972-09

3.  Sterols from polyene-resistant mutants of Candida albicans.

Authors:  J M Hamilton-Miller
Journal:  J Gen Microbiol       Date:  1972-11

4.  Resistance to polyene antibiotics and correlated sterol changes in two isolates of Candida tropicalis from a patient with an amphotericin B-resistant funguria.

Authors:  R A Woods; M Bard; I E Jackson; D J Drutz
Journal:  J Infect Dis       Date:  1974-01       Impact factor: 5.226

5.  Development of strains of Cryptococcus neoformans resistant to nystatin, amphotericin B, trichomycin and polymyxin B.

Authors:  J Bodenhoff
Journal:  Acta Pathol Microbiol Scand       Date:  1968

6.  Sterol mutants of Neurospora crassa: their isolation, growth characteristics and resistance to polyene antibiotics.

Authors:  M Grindle
Journal:  Mol Gen Genet       Date:  1973-02-02

7.  Polyene-resistant mutants of Aspergillus fennelliae: sterol content and genetics.

Authors:  S J Kim; K J Kwon-Chung
Journal:  Antimicrob Agents Chemother       Date:  1974-07       Impact factor: 5.191

8.  8(9),22 -Ergostadiene-3 -ol, an ergosterol precursor accumulated in wild-type and mutants of yeast.

Authors:  L W Parks; F T Bond; E D Thompson; P R Starr
Journal:  J Lipid Res       Date:  1972-05       Impact factor: 5.922

9.  Biochemical and genetic aspects of nystatin resistance in saccharomyces cerevisiae.

Authors:  M Bard
Journal:  J Bacteriol       Date:  1972-09       Impact factor: 3.490

10.  Nystatin-resistant mutants of yeast: alterations in sterol content.

Authors:  R A Woods
Journal:  J Bacteriol       Date:  1971-10       Impact factor: 3.490

  10 in total
  10 in total

1.  Effect of ketoconazole on the fungicidal action of amphotericin B in Candida albicans.

Authors:  I J Sud; D S Feingold
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

2.  Sterol compositions and susceptibilities to amphotericin B of environmental Cryptococcus neoformans isolates are changed by murine passage.

Authors:  B Currie; H Sanati; A S Ibrahim; J E Edwards; A Casadevall; M A Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

3.  Solid-state NMR spectroscopy identifies three classes of lipids in Cryptococcus neoformans melanized cell walls and whole fungal cells.

Authors:  Christine Chrissian; Emma Camacho; John E Kelly; Hsin Wang; Arturo Casadevall; Ruth E Stark
Journal:  J Biol Chem       Date:  2020-08-28       Impact factor: 5.157

4.  Sterol composition of Cryptococcus neoformans in the presence and absence of fluconazole.

Authors:  M A Ghannoum; B J Spellberg; A S Ibrahim; J A Ritchie; B Currie; E D Spitzer; J E Edwards; A Casadevall
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

5.  Erg6 affects membrane composition and virulence of the human fungal pathogen Cryptococcus neoformans.

Authors:  Fabiana Freire M Oliveira; Hugo Costa Paes; Luísa Defranco F Peconick; Fernanda L Fonseca; Clara Luna Freitas Marina; Anamélia Lorenzetti Bocca; Mauricio Homem-de-Mello; Márcio Lourenço Rodrigues; Patrícia Albuquerque; André Moraes Nicola; J Andrew Alspaugh; Maria Sueli S Felipe; Larissa Fernandes
Journal:  Fungal Genet Biol       Date:  2020-03-19       Impact factor: 3.495

6.  Incidence of polyene-resistant yeasts recovered from clinical specimens.

Authors:  J D Dick; W G Merz; R Saral
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191

7.  Effect of amphotericin B on the lipids of five different strains of Cryptococcus neoformans.

Authors:  S P Franzot; J S Hamdan
Journal:  Mycopathologia       Date:  1994-11       Impact factor: 2.574

Review 8.  The capsule of Cryptococcus neoformans.

Authors:  Arturo Casadevall; Carolina Coelho; Radames J B Cordero; Quigly Dragotakes; Eric Jung; Raghav Vij; Maggie P Wear
Journal:  Virulence       Date:  2018-08-01       Impact factor: 5.882

Review 9.  Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications.

Authors:  Thomas R Rogers; Paul E Verweij; Mariana Castanheira; Eric Dannaoui; P Lewis White; Maiken Cavling Arendrup
Journal:  J Antimicrob Chemother       Date:  2022-07-28       Impact factor: 5.758

10.  Bis(N-picolinamido)cobalt(II) Complexes Display Antifungal Activity toward Candida albicans and Aspergillus fumigatus.

Authors:  Laura H D Ghandhi; Stefan Bidula; Christopher M Pask; Rianne M Lord; Patrick C McGowan
Journal:  ChemMedChem       Date:  2021-07-29       Impact factor: 3.540

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.